| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.17B | +127.3% |
| Gross profit | ¥0.08B | — |
| Operating income | ¥0.04B | — |
| Net income | ¥0.03B | +3.5% |
| Gross margin | 49.4% | Net margin 19.0% |
| Revenue Q/Q | -21.7% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.08B | 50.6% |
| R&D | ¥0.01B | 7.7% |
| SG&A | ¥0.03B | 20.3% |
| Tax & other | ¥0.01B | 4.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
经纬股份 ・ 卡莱特 ・ 汇成真空 ・ 昊帆生物 ・ 仁信新材 ・ 宏景科技 ・ 溯联股份 ・ 星源卓镁 ・ 英特科技 ・ 华人健康 ・ 安培龙 ・ 协昌科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies